{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:11:47Z","timestamp":1792523507642,"version":"4.5.0"},"reference-count":56,"publisher":"Akademiai Kiado Zrt.","issue":"2","content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["AMicr"],"published-print":{"date-parts":[[2021,6,21]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present study evaluated the carbapenem resistance mechanisms of <jats:italic>Klebsiella pneumoniae<\/jats:italic> strains isolated in two Greek tertiary teaching hospitals and their susceptibility to currently used and novel antimicrobial agents.<\/jats:p><jats:p>Forty-seven carbapenem resistant <jats:italic>K. pneumoniae<\/jats:italic> strains were collected in G. Papanikolaou and Ippokrateio hospital of Thessaloniki between 2016 and 2018. Strain identification and antimicrobial susceptibility was conducted by Vitek 2 system (Biom\u00e9rieux France). Susceptibility against new antimicrobial agents was examined by disk diffusion method. Polymerase chain reaction (PCR) was used to detect <jats:italic>bla<\/jats:italic><jats:sub>KPC<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>VIM<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>NDM<\/jats:sub> and <jats:italic>bla<\/jats:italic><jats:sub>OXA-48<\/jats:sub> genes.<\/jats:p><jats:p>The meropenem\u2013EDTA and meropenem\u2013boronic acid synergy test performed on the 24 <jats:italic>K. pneumoniae<\/jats:italic> strains demonstrated that 8 (33.3%) yielded positive for metallo-beta-lactamases (MBL) and 16 (66.6%) for <jats:italic>K. pneumonia<\/jats:italic> carbapenemases (KPC) production. Colistin demonstrated the highest <jats:italic>in vitro<\/jats:italic> activity (87.7%) among the 47 <jats:italic>K. pneumoniae<\/jats:italic> strains followed by gentamicin (76.5%) and tigecycline (51%). Among new antibiotics ceftazidime\/avibactam showed the highest sensitivity (76.6%) in all strains followed by eravacycline (66.6%). The <jats:italic>bla<\/jats:italic><jats:sub>KPC<\/jats:sub> gene was present in 30 strains (63.8%), the <jats:italic>bla<\/jats:italic><jats:sub>NDM<\/jats:sub> in 11 (23.4%) and the <jats:italic>bla<\/jats:italic><jats:sub>VIM<\/jats:sub> in 6 (12.8%). The <jats:italic>bla<\/jats:italic><jats:sub>OXA-48<\/jats:sub> gene was not detected.<\/jats:p><jats:p>Well established antimicrobial agents such as colistin, gentamicin and tigecycline and novel antibiotics like ceftazidime\/avibactam and eravacycline can be reliable options for the treatment of invasive infections caused by carbapenem-resistant <jats:italic>K. pneumoniae<\/jats:italic>.<\/jats:p>","DOI":"10.1556\/030.2021.01364","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T11:47:12Z","timestamp":1614599232000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":5,"title":["Ceftazidime\/avibactam and eravacycline susceptibility of carbapenem-resistant Klebsiella pneumoniae in two Greek tertiary teaching hospitals"],"prefix":"10.1556","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2101-4546","authenticated-orcid":true,"given":"Maria","family":"Chatzidimitriou","sequence":"first","affiliation":[{"name":"1School of Biomedical Sciences, International Hellenic University, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Chatzivasileiou","sequence":"additional","affiliation":[{"name":"2Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Sakellariou","sequence":"additional","affiliation":[{"name":"3Medical School, Demokritus University of Thrace, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MariaAnna","family":"Kyriazidi","sequence":"additional","affiliation":[{"name":"2Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asimoula","family":"Kavvada","sequence":"additional","affiliation":[{"name":"1School of Biomedical Sciences, International Hellenic University, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Chatzidimitriou","sequence":"additional","affiliation":[{"name":"2Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fani","family":"Chatzopoulou","sequence":"additional","affiliation":[{"name":"2Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Meletis","sequence":"additional","affiliation":[{"name":"2Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mavridou","sequence":"additional","affiliation":[{"name":"1School of Biomedical Sciences, International Hellenic University, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Rousis","sequence":"additional","affiliation":[{"name":"2Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Katsifa","sequence":"additional","affiliation":[{"name":"4General Teaching Hospital \u201cG. Papanikolaou\u201d, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Vagdatli","sequence":"additional","affiliation":[{"name":"5General Teaching Hospital \u201cIppokrateio\u201d, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Mitka","sequence":"additional","affiliation":[{"name":"1School of Biomedical Sciences, International Hellenic University, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lialiaris","family":"Theodoros","sequence":"additional","affiliation":[{"name":"3Medical School, Demokritus University of Thrace, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"ref401","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/dkl481","article-title":"Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases","volume":"59","author":"Ellington","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1128\/JCM.01017-15","article-title":"Large Nosocomial outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant","volume":"53","author":"Giani","year":"2015","journal-title":"J Clin Microbiol"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cmi.2017.11.020","article-title":"Antimicrobial susceptibility testing of colistin \u2013 evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp","volume":"24","author":"Matuschek","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.12688\/f1000research.11532.1","article-title":"Recent advances in the understanding and management of Klebsiella pneumoniae","volume":"6","author":"Calfee","year":"2017","journal-title":"F1000Res"},{"key":"ref501","first-page":"15","article-title":"Carbapenem resistance: overview of the problem and future perspectives","volume":"3","author":"Meletis","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/JCM.02163-10","article-title":"Detection of Klebsiella pneumoniae carbapenemase (KPC) production in non-Klebsiella pneumoniae Enterobacteriaceae isolates by use of the Phoenix, Vitek 2, and disk diffusion methods","volume":"49","author":"Doern","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref381","first-page":"3","article-title":"Laboratory manual for carbapenem and colistin resistance detection and characterisation for the survey of carbapenem- and\/or colistin-resistant Enterobacteriaceae","volume":"2","author":"Albiger","year":"2019","journal-title":"ECDC"},{"key":"ref01","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.07.20086-en","article-title":"Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiella pneumoniae in Spain, September 2009 to February 2010: control measures","volume":"17","author":"Robustillo Rodela","year":"2012","journal-title":"Euro Surveill"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017 Feb","journal-title":"Lancet Infect Dis"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1099\/jmm.0.000217","article-title":"A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates","volume":"65","author":"Spyropoulou","year":"2016","journal-title":"J Med Microbiol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1099\/jmm.0.000217","article-title":"A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates","volume":"65","author":"Spyropoulou","year":"2016","journal-title":"J Med Microbiol"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1128\/AAC.02841-15","article-title":"Assessment of the in vitro activity of ceftazidime-avibactam against multidrug-resistant Klebsiella spp. collected in the INFORM global surveillance study, 2012 to 2014","volume":"60","author":"Hackel","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1128\/AAC.04809-14","article-title":"Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City","volume":"59","author":"Abdallah","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"van Duin","year":"2017","journal-title":"Virulence"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"e01960","DOI":"10.1128\/JCM.01960-17","article-title":"Assessment of 30\/20-Microgram disk content versus MIC results for ceftazidime-avibactam tested against Enterobacteriaceae and Pseudomonas aeruginosa","volume":"56","author":"Sader","year":"2018","journal-title":"J Clin Microbiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.01922-08","article-title":"Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory","volume":"47","author":"Tsakris","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref301","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.07.20086-en","article-title":"Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiella pneumoniae in Spain, September 2009 to February 2010: control measures","volume":"17","author":"Robustillo Rodela","year":"2012","journal-title":"Euro Surveill"},{"key":"ref151","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.30.1700775","article-title":"Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016","volume":"23","author":"Galani","year":"2018","journal-title":"Euro Surveill"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"e02369","DOI":"10.1128\/AAC.02369-16","article-title":"Low frequency of ceftazidime-avibactam resistance among Enterobacteriaceae isolates carrying blaKPC collected in U.S. Hospitals from 2012 to 2015","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1128\/JCM.01017-15","article-title":"Large Nosocomial outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant","volume":"53","author":"Giani","year":"2015","journal-title":"J Clin Microbiol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"van Duin","year":"2017","journal-title":"Virulence"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cmi.2017.11.020","article-title":"Antimicrobial susceptibility testing of colistin \u2013 evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp","volume":"24","author":"Matuschek","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1128\/AAC.01288-13","article-title":"Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens","volume":"57","author":"Sutcliffe","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1128\/AAC.01288-13","article-title":"Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens","volume":"57","author":"Sutcliffe","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","article-title":"Multiplex PCR for detection of acquired carbapenemase genes","volume":"70","author":"Poirel","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jgar.2013.06.002","article-title":"Action Plan to combat infections due to carbapenem-resistant, Gram-negative pathogens in acute-care hospitals in Greece","volume":"2","author":"Maltezou","year":"2014","journal-title":"J Glob Antimicrob Resist"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.12688\/f1000research.11532.1","article-title":"Recent advances in the understanding and management of Klebsiella pneumoniae","volume":"6","author":"Calfee","year":"2017","journal-title":"F1000Res"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1128\/AAC.04809-14","article-title":"Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City","volume":"59","author":"Abdallah","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"ref431","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062","article-title":"Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015","volume":"20","author":"Albiger","year":"2015","journal-title":"Euro Surveill"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"e02369","DOI":"10.1128\/AAC.02369-16","article-title":"Low frequency of ceftazidime-avibactam resistance among Enterobacteriaceae isolates carrying blaKPC collected in U.S. Hospitals from 2012 to 2015","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"ref81","first-page":"3","article-title":"Laboratory manual for carbapenem and colistin resistance detection and characterisation for the survey of carbapenem- and\/or colistin-resistant Enterobacteriaceae","volume":"2","author":"Albiger","year":"2019","journal-title":"ECDC"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017 Feb","journal-title":"Lancet Infect Dis"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","article-title":"Multiplex PCR for detection of acquired carbapenemase genes","volume":"70","author":"Poirel","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.01922-08","article-title":"Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory","volume":"47","author":"Tsakris","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/dkl481","article-title":"Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases","volume":"59","author":"Ellington","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jgar.2013.06.002","article-title":"Action Plan to combat infections due to carbapenem-resistant, Gram-negative pathogens in acute-care hospitals in Greece","volume":"2","author":"Maltezou","year":"2014","journal-title":"J Glob Antimicrob Resist"},{"key":"ref131","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062","article-title":"Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015","volume":"20","author":"Albiger","year":"2015","journal-title":"Euro Surveill"},{"key":"ref481","first-page":"417","article-title":"Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance","volume":"38","author":"Meletis","year":"2015","journal-title":"New Microbiol"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1128\/AAC.02841-15","article-title":"Assessment of the in vitro activity of ceftazidime-avibactam against multidrug-resistant Klebsiella spp. collected in the INFORM global surveillance study, 2012 to 2014","volume":"60","author":"Hackel","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13756-018-0435-9","article-title":"In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae","volume":"7","author":"Zhang","year":"2018","journal-title":"Antimicrob Resist Infect Contro"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/SMJ.0b013e3181fd7d5a","article-title":"Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria","volume":"104","author":"Arnold","year":"2011","journal-title":"South Med J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/JCM.02163-10","article-title":"Detection of Klebsiella pneumoniae carbapenemase (KPC) production in non-Klebsiella pneumoniae Enterobacteriaceae isolates by use of the Phoenix, Vitek 2, and disk diffusion methods","volume":"49","author":"Doern","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"e01960","DOI":"10.1128\/JCM.01960-17","article-title":"Assessment of 30\/20-Microgram disk content versus MIC results for ceftazidime-avibactam tested against Enterobacteriaceae and Pseudomonas aeruginosa","volume":"56","author":"Sader","year":"2018","journal-title":"J Clin Microbiol"},{"key":"ref451","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.30.1700775","article-title":"Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016","volume":"23","author":"Galani","year":"2018","journal-title":"Euro Surveill"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.6061\/clinics\/2012(12)13","article-title":"The modified Hodge test is a useful tool for ruling out Klebsiella pneumoniae carbapenemase","volume":"67","author":"Cury","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"ref561","first-page":"24","article-title":"Emergence of ceftazidime-avibactam-resistant Klebsiella pneumoniae during treatment, Finland, December 2018","author":"R\u00e4is\u00e4nen","year":"2019","journal-title":"Euro Surveill"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"ref261","first-page":"24","article-title":"Emergence of ceftazidime-avibactam-resistant Klebsiella pneumoniae during treatment, Finland, December 2018","author":"R\u00e4is\u00e4nen","year":"2019","journal-title":"Euro Surveill"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/SMJ.0b013e3181fd7d5a","article-title":"Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria","volume":"104","author":"Arnold","year":"2011","journal-title":"South Med J"},{"key":"ref181","first-page":"417","article-title":"Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance","volume":"38","author":"Meletis","year":"2015","journal-title":"New Microbiol"},{"key":"ref201","first-page":"15","article-title":"Carbapenem resistance: overview of the problem and future perspectives","volume":"3","author":"Meletis","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.6061\/clinics\/2012(12)13","article-title":"The modified Hodge test is a useful tool for ruling out Klebsiella pneumoniae carbapenemase","volume":"67","author":"Cury","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13756-018-0435-9","article-title":"In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae","volume":"7","author":"Zhang","year":"2018","journal-title":"Antimicrob Resist Infect Contro"}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/68\/2\/article-p65.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/030\/68\/2\/article-p65.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T23:30:21Z","timestamp":1651534221000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/68\/2\/article-p65.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":56,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1556\/030.2021.01364","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"value":"1217-8950","type":"print"},{"value":"1588-2640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,21]]}}}